Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RPN301
- Development stage
- Unknown
- Administration
- Intravenous
01
Overview
RPN301 is an investigational drug evaluated in a phase 3 clinical trial for use in postoperative patients requiring central parenteral nutrition. The study compares the safety and efficacy of IN-C006 Peri inj. and RPN301, indicating that RPN301 is intended as a treatment option for patients needing parenteral nutritional support after surgery. Specific details regarding its mechanism of action, molecular modality, or developer are not provided in the available sources[5].
Beyond the preview
Go deeper on RPN301.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RPN301.